**Specifications Table**TableSubject areaBiologyMore specific subject areaBreast cancer, *in vitro*, Anti-proliferative activity, PSG toxinType of dataFigureHow data was acquiredNikon Eclipse Ti-U Inverted Microscope, USA; Bio-Rad PR4100, USA Microtiter plate reader.Data formatAnalyzedExperimental factorsPeripheral blood mononuclear cells, MCF-7, KB, HeLa and A549 cancer cell lines were treated with PSG toxin from *S. pharaonis*.Experimental features**Lymphocyte migration inhibition assay**: Inhibition of LPS induced leucocyte migration by PSG toxin, observed in a Nikon Eclipse Ti-U Inverted Microscope, USA**MTT assay**: Reduction of MTT by mitochondrial succinate dehydrogenase in viable cancer cells treated with PSG toxin to a purple formazan product deteted in microplate reader**LDH release assay**: Reduction of the substrate lactate by LDH released into medium of cancer cells treated with PSG toxin, detected in microplate readerData source locationFaculty of Allied Health Sciences, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai, Tamil Nadu, India. 12.7948°N, 80.2160°EData accessibilityAll data are provided with this article

**Value of the data**•The provided data demonstrates the cytostatic potentials of the PSG toxin from *S. pharaonis* against peripheral blood mononuclear leucocytes.•The data provided illustrates the commendable anti-proliferative action of the PSG toxin from *S. pharaonis* against the selected cancer cell lines.•The data might be valuable to researchers interested in anti-proliferative action of toxins from marine mollusks.•The data might also be of value to researchers investigating the anti-proliferative and anticancer activity of marine bioactive compounds.

1. Data {#s0005}
=======

The migration of the lymphocytes was inhibited by the PSG toxin (5, 25 and 50 µg/ml) with a mean diameter of 1.65±0.55 mm and 1.42±0.64 mm respectively. The lymphocytes exhibited pronounced migration under the influence of LPS with a mean diameter of 3.45±0.83 mm ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Cytostatic activity of PSG toxin by inhibition of lymphocyte migration. Migration inhibition of PSG toxin against leucocytes. (A) Control leucocyte-agarose droplet (B) Migration of leucocytes from agarose droplet towards mitogen (). ![](fx1.gif)(C) Migration inhibition in presence of PSG toxin (5 μg/ml) (D) Migration inhibition in presence of PSG toxin (50 μg/ml).Fig. 1

The cell viability curve of the PSG toxin against the KB oral cancer cells with an IC~50~ concentration of 32.5 µM. The purified PSG toxin also exhibited significant inhibition against the proliferation of HeLa cervical cancer cells and A549 lung cancer cells at an IC~50~ value of 16.5 µg/ml (23.2 µM) and 22.45 µg/ml (31.65 µM) ([Fig. 2](#f0010){ref-type="fig"}). The inlet figure shows the cell viability in (A) control, (B) PSG toxin (100 μg/ml) and (C) Paclitaxel treated cells showing the zones of apoptosis.Fig. 2MTT cell viability curve of PSG toxin against (A) KB oral cancer cells (B) HeLa cervical cancer cells (C) A549 lung cancer cells. Microscopic images of (A) control, (B) PSG toxin treated and (C) paclitaxel treated cells indicating aggregation of apoptotic cells.Fig. 2

The PSG toxin also exhibited commendable LDH leakage against KB oral cancer cells, HeLa cervical cancer cells and A549 lung cancer cells with IC~50~ concentrations of 22.8 μg/ml, 17.45 μg/ml and 23.52 μg/ml respectively ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3LDH cell viability curve of PSG toxin against (A) KB oral cancer cells (B) HeLa cervical cancer cells (C) A549 lung cancer cells.Fig. 3

2. Materials and methods {#s0010}
========================

2.1. in vitro cytotoxicity {#s0015}
--------------------------

### 2.1.1. Lymphocyte migration inhibition assay {#s0020}

The cytotoxicity of the purified PSG toxin against the primary cells peripheral blood mononuclear cells (PBMC) was determined using the lymphocyte migration inhibition assay following the method of Mousseau et al. (2007). The inhibition of leucocyte migration treated with PSG toxin (5,10,50 µg/ml) under the influence of mitogen (lipopolysaccharide) was measured using a microscope ruler [@bib2].

### 2.1.2. *in vitro* anticancer activity by MTT assay {#s0025}

The cytotoxicity of the purified PSG toxin against selected cancer cell lines was determined by the MTT cell viability assay [@bib3]. The anti-proliferative potentials of the PSG toxin (0.5,1,5,10,25,50 µg/ml) was studied against the adherent cultures of KB (oral), HeLa (cervical) and A549 (lung) cancer cell line and the inhibitory concentrations (IC~50~) were determined.

### 2.1.3. LDH release assay {#s0030}

The cell viability and membrane permeability of the PSG toxin (0.5,1,5,10,25, 50 µg/ml) against the KB, HeLa and A549 cancer cells was determined using the LDH leakage assay [@bib4]. The inhibitory effect of the PSG toxin on the mitochondrial enzymes, dehydrogenases are evaluated by the levels of LDH released into medium after action on the substrate lactate in the presence of NADH.
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